Tirzepatide and Hormone Therapy Synergy: Enhanced Weight Loss in Women and Implications for Men on TRT In the evolving landscape of metabolic and hormone optimization therapies, tirzepatide (Mounjaro/Zepbound) stands out as a powerful dual GLP-1/GIP receptor agonist for obesity, type 2 diabetes, and insulin resistance. Recent real-world evidence highlights its amplified effects when combined with…
Read more
Tirzepatide and HRT Synergy: Boosting Weight Loss in Women and Potential Benefits for Men on TRT




